ValuationViz

CVS 13F position history: Prem Watsa - Fairfax Financial Holdings

CVS Health Corporation, as reported in Prem Watsa - Fairfax Financial Holdings’s quarterly 13F filings. See all fund managers holding CVS.

QuarterActivitySharesValue% of portfolioReported price
Q2 2026No change2,712,000$280,502,16010.6%$103.43Filing
Q1 2026No change2,712,000$194,775,84010.0%$71.82Filing
Q4 2025No change2,712,000$215,197,20010.3%$79.35Filing
Q3 2025No change2,712,000$204,376,3209.90%$75.36Filing
Q2 2025No change2,712,000$186,965,2809.99%$68.94Filing
Q1 2025No change2,712,000$183,765,1209.96%$67.76Filing
Q4 2024New2,712,000$121,741,6807.82%$44.89Filing
Q2 2024Sold out——0.00%—Filing
Q1 2024No change15,000$1,195,9500.10%$79.73Filing
Q4 2023No change15,000$1,184,1000.08%$78.94Filing
Q3 2023No change15,000$1,047,4500.07%$69.83Filing
Q2 2023No change15,000$1,036,9500.07%$69.13Filing
Q1 2023No change15,000$1,114,5000.08%$74.30Filing
Q4 2022No change15,000$1,397,8500.04%$93.19Filing
Q3 2022No change15,000$1,431,0000.04%$95.40Filing
Q2 2022Trimmed15,000$1,390,0000.05%$92.67Filing
Q1 2022No change26,500$2,682,0000.09%$101.21Filing
Q4 2021No change26,500$2,733,0000.09%$103.13Filing
Q3 2021No change26,500$2,248,0000.07%$84.83Filing
Q2 2021No change26,500$2,211,0000.07%$83.43Filing
Q1 2021No change26,500$1,993,0000.07%$75.21Filing
Q4 2020No change26,500$1,809,0000.08%$68.26Filing
Q3 2020No change26,500$1,547,0000.09%$58.38Filing
Q2 2020No change26,500$1,720,0000.11%$64.91Filing
Q1 2020No change26,500$1,574,0000.11%$59.40Filing
Q4 2019New26,500$1,968,0000.10%$74.26Filing